Search Results
Found 1 results
510(k) Data Aggregation
(292 days)
Enzyme linked immunoassays (ELISA) for the qualitative and semiquantitative detection of anti-human Tissue Transglutaminase IgA or IgG antibodies in human serum to aid in the diagnosis of gluten sensitive enteropathy / celiac disease (CD) in conjunction with other laboratory and clinical findinas.
Not Found
I am sorry, but the provided text is a cover letter from the FDA regarding a 510(k) premarket notification for an in vitro diagnostic device (ImmuLisa Celiac TtG rHuman Tissue Transglutaminase Antibody ELISAs).
While it mentions the device, its intended use, and substantial equivalence to a predicate device, it does NOT contain any information about:
- Acceptance criteria or reported device performance.
- Sample sizes or data provenance for a test set.
- Number or qualifications of experts for ground truth establishment.
- Adjudication method.
- Multi-reader multi-case (MRMC) comparative effectiveness studies.
- Standalone algorithm performance.
- Type of ground truth used (e.g., pathology, outcomes data).
- Sample size for the training set.
- How ground truth for the training set was established.
This document is a regulatory approval letter, not a scientific study report or a summary of performance data. Therefore, I cannot extract the requested information from the provided text.
Ask a specific question about this device
Page 1 of 1